![](/img/cover-not-exists.png)
Phase I study of cladribine, cytarabine (Ara-C), granulocyte colony stimulating factor (G-CSF) (CLAG Regimen) and simultaneous escalating doses of imatinib mesylate (Gleevec) in relapsed/refractory AML
Alison R. Walker, Rami S. Komrokji, Jainulabdeen Ifthikharuddin, Patti Messina, Deborah Mulford, Michael Becker, Jonathan Friedberg, Jamie Oliva, Gordon Phillips, Jane L. Liesveld, Camille AbboudVolume:
32
Year:
2008
Language:
english
Pages:
7
DOI:
10.1016/j.leukres.2008.04.026
File:
PDF, 208 KB
english, 2008